• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCambium Bio
    Picture of Cambium Bio logo

    CMB — Cambium Bio Share News

    AU$0.450.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      AU$12.30m
    • Enterprise Value
      AU$11.33m
    • Revenue
      AU$0.64m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CMB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CMB Dividends
    • Revised Date of AGM

      20/09/2021 01:00
    • Appendix 4E - Preliminary final report-unaudited

      31/08/2021 05:03
    • PRE_NR Ends: 14:14:20

      31/08/2021 05:03
    • Date of AGM

      19/08/2021 08:57
    • Lapse of Unlisted Share Options - correction

      09/08/2021 06:05
    • Notification of cessation of securities - RGS

      09/08/2021 05:20
    • Lapse of Unlisted Share Options

      09/08/2021 24:50
    • Company Secretary Appointment/Resignation

      30/06/2021 09:48
    • Appendix 2A

      12/05/2021 06:58
    • Cleansing Statement

      12/05/2021 06:53
    • Brief: Regeneus Ltd Announces Institutional Placement To Raise Up To $5.5 Mln

      07/05/2021 02:20
    • Proposed issue of Securities - RGS

      07/05/2021 24:47
    • Regeneus Announces Institutional Placement

      07/05/2021 24:33
    • PRE_NR Ends: 09:44:45

      07/05/2021 24:33
    • Grant of Options to CEO and Appendix 3G

      05/05/2021 24:43
    • Appendix 4C - Quarterly

      30/04/2021 24:49
    • PRE_NR Ends: 10:00:43

      30/04/2021 24:49
    • PRE_NR Ends: 10:00:05

      29/04/2021 24:49
    • Regeneus partners with Defence to treat combat casualties

      29/04/2021 24:49
    • Brief: Regeneus To Be Granted Key Progenza Patent In Europe

      16/03/2021 01:52
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.